Considering that SerRS exhibits a suppressive effect on multiple pathways, such as angiogenesis, lipogenesis, and telomere elongation, all of which contribute to tumor development and progression, SerRS can be regarded as a tumor suppressor and potential anti-tumor drug target or therapeutic agent. The gene discussed is SARS2; the disease is neoplasm.